We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cvs Group Plc | LSE:CVSG | London | Ordinary Share | GB00B2863827 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
20.00 | 2.09% | 975.00 | 970.00 | 975.00 | 982.00 | 946.00 | 947.00 | 779,437 | 16:29:55 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Veterinary Svcs-animal Specs | 608.3M | 41.9M | 0.5843 | 16.69 | 699.2M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/3/2022 14:21 | Buy backs are for more mature businesses… I would prefer they buy more veterinary practices overseas….or diversify into pet care products they can sell through the existing practices… Or build new animal hospitals and consolidate their services into bigger hubs to deliver better care solutions…thes One of these and the difference to the local practice is immense. I don’t think I will be using the local vet for anything soon beyond convenient check ups. Order regular treatments for flea and worms online. Go the specialist centr for anything abnormal pay for good insurance but with a higher excess to keep the premiums down | 1jat | |
24/3/2022 10:04 | It sounds like share buybacks coming soon, possibly £100m+ available to spend. | spyder | |
24/3/2022 09:19 | CVS Group (CVSG) 2022 interim results overview March 2022 CEO, Richard Fairman summarises the interim results for the period ended 31 December 2021. Watch the video here: Or listen to the podcast here: | tomps2 | |
24/3/2022 08:06 | Decent ongoing results…..more please in H2. Avoiding a fight with CMA is sensible as it would tie up resources for a while but maybe just defers the pain….CMA could just change their mind and go to 25% or 20% local market share…. They will just need to be more selective and maybe the small chains will need to break themselves up selling to multiple parties….as is pointed out there is still a large runway of potential acquisitions. Veterinary practice is changing with local vets linked into referral centres it is gettting more like a human private health service funded by self pay and insurance. | 1jat | |
24/3/2022 08:01 | Another set of strong results. Shame about the CMA decision re QPC, at least it informs future targeting. | lomax99 | |
23/3/2022 11:01 | On the technical side a break up thru £18 will break the current 6 month decline. Fingers crossed | prokartace | |
23/2/2022 09:32 | All happening while there's a nation-wide shortage of vets apparently.If true, that might be the root cause of the problem for the CMA & not CVS's business model. | dogwalker | |
21/2/2022 16:42 | The CMA has surely got its sums wrong…..how can a little deal result in such an anti competitive situation. I live in Bristol and can tell you there are many alternatives to CVSG and I have never heard of The Vet as a provider, maybe they are dominant in a particular district but it is getting v localised. I think there are more vet practices than supermarkets…. CVSG need to beat the CMA. | 1jat | |
21/2/2022 09:55 | Robertball, seven! | wad collector | |
20/2/2022 16:23 | Outlook The board of CVS remains confident in the future growth prospects of the Group and will provide further detail on current trading and the outlook for the full year when it publishes the Group's interim financial results for the six month period ended 31 December 2021 on 24 March 2022. | ariane | |
20/2/2022 12:44 | (MT Newswires) -- The UK Competition and Markets Authority is initiating an in-depth investigation into CVS Group's (CVSG.L) acquisition of Quality Pet Care, also known as The Vet. The move follows a phase 1 investigation into the deal, which was found to raise competition concerns in five local areas in the UK, according to a Friday filing. The locations are Bristol, Nottingham, Portsmouth, Southampton and Warrington. CVS has five working days to address the concerns. CVS shares were down almost 1% at Thursday's close. Price (GBP): £1874.00, Change: £-10.00, Percent Change: -0.53% | adrian j boris | |
18/2/2022 19:22 | What bite would be smaller than 8 practices? | robertball | |
18/2/2022 17:32 | Almost exactly back to the share price that I acquired a year ago. I guess , assuming that they do not challenge the CMA comment, they will still try to grow but by smaller bites. Must confess that I do not always follow the logic of company growth, sometimes it is better to be good at what you do rather than reach out too far; many a company has come unstuck trying to expand too fast. Veterinary customers don't all want to go to a shiny chain store , many prefer the local familiar. | wad collector | |
18/2/2022 15:53 | Scalping like a barsteward me! lol | bulltradept | |
18/2/2022 15:48 | price looks pretty good from where I bought | prokartace | |
18/2/2022 13:17 | Robertball, The problem you have with modern market is they are now inhabited with algos. Sometimes today's price doesn't reflect tomorrow's or next week's. | bulltradept | |
18/2/2022 13:11 | On ignore btmarquesbr | bulltradept | |
18/2/2022 12:47 | Anyway, the share price reaction tells youAll you need to know. Avoid | robertball | |
18/2/2022 12:47 | Well it cannot any more practices. | robertball | |
18/2/2022 12:24 | Robertball, please explain why it is ex growth | prokartace | |
18/2/2022 11:35 | —>RB CVS hasn’t really grown much by acquisition in the last 3 or 4 years, it has almost all been organic growth and that will continue. | spyder | |
18/2/2022 11:30 | Never sell at 11.30 | niggle | |
18/2/2022 10:47 | Not really. CVSG is now ex growth. | robertball | |
18/2/2022 10:11 | Bit hit to the share price this morning, out of proportion to the news as this is a minor development overall, an opportunity for the brave? | spyder |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions